Biomerica
BMRA
28 hedge funds and large institutions have $11.3M invested in Biomerica in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 0 closing their positions.
1,700% more call options, than puts
Call options by funds: $828K | Put options by funds: $46K
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
21% more capital invested
Capital invested by funds: $9.29M → $11.3M (+$1.97M)
17% more funds holding
Funds holding: 24 → 28 (+4)
0.06% more ownership
Funds ownership: 2.39% → 2.45% (+0.06%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$280K |
| 2 |
RI
Ridgewood Investments
Springfield,
New Jersey
|
+$249K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$136K |
| 4 |
Jane Street
New York
|
+$53.3K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$37.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$189K |
| 2 |
HWA
HCR Wealth Advisors
Los Angeles,
California
|
-$41.6K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$15.4K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$831 |
BMRA Hedge Fund Activity: Q1 2022 in Review
28 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q1 2022, worth a combined $11.3M — up 21% from $9.29M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BMRA positions and 0 closed out — a net gain of 4 holders — while 7 added to existing stakes and 4 trimmed.
The largest buyer was Granahan Investment Management, adding an estimated $280K. The largest seller was Group One Trading, cutting an estimated $189K.
- 28 institutional investors held Biomerica (BMRA) as of Q1 2022, up from 24 in Q4 2021.
- Funds reported $11.3M of Biomerica stock for Q1 2022, up 21% quarter-over-quarter.
- 4 funds opened new Biomerica positions in Q1 2022 and 0 closed out, a net change of +4 holders.
- The largest Biomerica buyer in Q1 2022 was Granahan Investment Management, an estimated $280K added.
- The largest Biomerica seller in Q1 2022 was Group One Trading, an estimated $189K sold.
Based on aggregated 13F filings for Q1 2022.